// App-Quantinova.ai

: 3,023 Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Researchers

Presenter

  • Natasha Szuber

Principal Investigators

  • Maura Nicolosi

  • Domenico Penna

  • Rangit Vallapureddy

  • Terra L. Lasho

  • Christy Finke

  • Kebede H. Begna

  • Michelle A. Elliott

  • C. Christopher Hook

  • Alexandra Wolanskyj

  • Mrinal M. Patnaik

  • Curtis A. Hanson

  • Rhett P. Ketterling

  • Shireen Sirhan

  • Animesh Pardanani

  • Naseema Gangat

  • Lambert Busque

  • Ayalew Tefferi

Medical Centers

  • Division of Medical Oncology, Mayo Clinic, Rochester, MN

  • Division of Hematopathology, Mayo Clinic, Rochester, MN

  • Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN

  • Division of Respirology, Jewish General Hospital, Montreal, QC, Canada

  • Department of Laboratory Hematology, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Myeloid neoplasms

  • Venous thrombosis

Biomarkers

  • Proteasome Subunit Beta 8

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved